Review



sk3  (Cytek Biosciences)


Bioz Verified Symbol Cytek Biosciences is a verified supplier
Bioz Manufacturer Symbol Cytek Biosciences manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cytek Biosciences sk3
    Sk3, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/cFluor+B548+Anti-Human+CD4/pmc12643170-494-5-7
    Average 93 stars, based on 8 article reviews
    sk3 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Infection:

    Article Title: Chikungunya virus-specific CD4 + T cells are associated with chronic chikungunya viral arthritic disease in humans.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Live/Dead Blue ThermoFisher Cat#L23105 CCR6-BUV496 BD Biosciences Clone# 11A9; Cat# 612948; RRID:AB_2833076 CXCR5-BV421 BioLegend Clone# J252D4; Cat# 356920; RRID:AB_2562303 CXCR3-BV605 BioLegend Clone# G025H7; Cat# 353728; RRID:AB_2563157 CCR7-BV711 BioLegend Clone# G043H7; Cat# 353228; RRID:AB_2563865 CD3-BUV395 BD Biosciences Clone# UCHT1; Cat# 563546; RRID:AB_2744387 CD137-BUV737 BD Biosciences Clone# 4B4-1; Cat# 741861; RRID:AB_2871191 CD8-BUV805 BD Biosciences Clone# SK1; Cat# 612889; RRID:AB_2833078 CD16-BV510 BioLegend Clone# 3G8; Cat# 302048; RRID:AB_2562085 CD14-BV510 BioLegend Clone# 63D3; Cat# 367124; RRID:AB_2716229 CD20-BV510 BioLegend Clone# 2H7; Cat# 302340; RRID:AB_2561941 CD45RA-BV570 BioLegend Clone# HI100; Cat# 304132; RRID:AB_2563813 CD38-BV650 BioLegend Clone# HB-7; Cat# 356620; RRID:AB_2566233 PD-1-BV785 BioLegend Clone# EH12.2H7; Cat# 329930; RRID:AB_2563443 CD69-FITC BioLegend Clone# FN50; Cat# 310904; RRID:AB_314839 CD4-cFluor B548 Cytek Biosciences Clone# SK3; Cat# R7-20043 CD95-BB700 BD Biosciences Clone# DX2; Cat# 566542; RRID:AB_2869780 CD40L-PE-Dazzle594 BioLegend Clone# 24–31; Cat# 310840; RRID:AB_2566245 OX40-APC BioLegend Clone# Ber-Act35; Cat# 350008; RRID:AB_10719958 HLA-DR-APC-R700 BD Biosciences Clone# G46-6; Cat# 565127; RRID:AB_2732055 CD40 Miltenyi Biotec Clone# HB14; Cat# 130-094-133; RRID:AB_10839704 CCR7-PE-Cy7 BioLegend Clone# G043H7; Cat# 353226; RRID:AB_11126145 IL-4-BUV737 BD Biosciences Clone# MP4-25D2; Cat# 612835; RRID:AB_2870157) IL-17-BV785 BioLegend Clone# BL168; Cat# 512338; RRID:AB_2566765 IFNγ-FITC Thermo Fisher Clone# 4S.B3; Cat# 11-7319-82; RRID:AB_465415) IL-2-BB700 BD Biosciences Clone# MQ1-17H12; Cat# 566405; RRID:AB_2744488 IL-10 -PE-Dazzle594 BioLegend Clone# JES3-19F1; Cat# 506812; RRID:AB_2632783 TNFα-eFluor450 Thermo Fisher Clone# Mab11; Cat# 48-7349-42; RRID:AB_2043889 Granzyme B-AF647 BD Biosciences Clone# GB11; Cat# 560212; RRID:AB_11154033 CD40L-PerCP-ef710 Thermo Fisher Clone# 24–31; Cat# 46-1548-42; RRID:AB_10670357 CD137-PE-Cy5 BD Biosciences Clone# 4B4-1; Cat# 551137; RRID:AB_394067 IgG Fc secondary Ab Southern Biotech Cat# 2014-09; RRID:AB_2795582 FluoroSpot: Human IFNγ (490) Mabtech, Sweden Cat# FSP-01A-2 Biological samples CHIKV infected and uninfected blood samples Barranquilla, Colombia N/A Chemicals, peptides, and recombinant proteins Synthetic peptides TC Peptide lab https://tcpeptidelab.com/ Critical commercial assays CD4 MicroBeads Miltenyi Biotec Cat# 130-097-048 Deposited data Raw data values This paper Mendeley Data: https://doi.org/10.17632/h6hdnj35x6.1 Software and algorithms FlowJo BD Life Sciences 10.8.1 GraphPad Prism GraphPad Software 10 e1 Cell Reports Medicine 6, 102134, May 20, 2025 ..

    Recombinant:

    Article Title: Chikungunya virus-specific CD4 + T cells are associated with chronic chikungunya viral arthritic disease in humans.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Live/Dead Blue ThermoFisher Cat#L23105 CCR6-BUV496 BD Biosciences Clone# 11A9; Cat# 612948; RRID:AB_2833076 CXCR5-BV421 BioLegend Clone# J252D4; Cat# 356920; RRID:AB_2562303 CXCR3-BV605 BioLegend Clone# G025H7; Cat# 353728; RRID:AB_2563157 CCR7-BV711 BioLegend Clone# G043H7; Cat# 353228; RRID:AB_2563865 CD3-BUV395 BD Biosciences Clone# UCHT1; Cat# 563546; RRID:AB_2744387 CD137-BUV737 BD Biosciences Clone# 4B4-1; Cat# 741861; RRID:AB_2871191 CD8-BUV805 BD Biosciences Clone# SK1; Cat# 612889; RRID:AB_2833078 CD16-BV510 BioLegend Clone# 3G8; Cat# 302048; RRID:AB_2562085 CD14-BV510 BioLegend Clone# 63D3; Cat# 367124; RRID:AB_2716229 CD20-BV510 BioLegend Clone# 2H7; Cat# 302340; RRID:AB_2561941 CD45RA-BV570 BioLegend Clone# HI100; Cat# 304132; RRID:AB_2563813 CD38-BV650 BioLegend Clone# HB-7; Cat# 356620; RRID:AB_2566233 PD-1-BV785 BioLegend Clone# EH12.2H7; Cat# 329930; RRID:AB_2563443 CD69-FITC BioLegend Clone# FN50; Cat# 310904; RRID:AB_314839 CD4-cFluor B548 Cytek Biosciences Clone# SK3; Cat# R7-20043 CD95-BB700 BD Biosciences Clone# DX2; Cat# 566542; RRID:AB_2869780 CD40L-PE-Dazzle594 BioLegend Clone# 24–31; Cat# 310840; RRID:AB_2566245 OX40-APC BioLegend Clone# Ber-Act35; Cat# 350008; RRID:AB_10719958 HLA-DR-APC-R700 BD Biosciences Clone# G46-6; Cat# 565127; RRID:AB_2732055 CD40 Miltenyi Biotec Clone# HB14; Cat# 130-094-133; RRID:AB_10839704 CCR7-PE-Cy7 BioLegend Clone# G043H7; Cat# 353226; RRID:AB_11126145 IL-4-BUV737 BD Biosciences Clone# MP4-25D2; Cat# 612835; RRID:AB_2870157) IL-17-BV785 BioLegend Clone# BL168; Cat# 512338; RRID:AB_2566765 IFNγ-FITC Thermo Fisher Clone# 4S.B3; Cat# 11-7319-82; RRID:AB_465415) IL-2-BB700 BD Biosciences Clone# MQ1-17H12; Cat# 566405; RRID:AB_2744488 IL-10 -PE-Dazzle594 BioLegend Clone# JES3-19F1; Cat# 506812; RRID:AB_2632783 TNFα-eFluor450 Thermo Fisher Clone# Mab11; Cat# 48-7349-42; RRID:AB_2043889 Granzyme B-AF647 BD Biosciences Clone# GB11; Cat# 560212; RRID:AB_11154033 CD40L-PerCP-ef710 Thermo Fisher Clone# 24–31; Cat# 46-1548-42; RRID:AB_10670357 CD137-PE-Cy5 BD Biosciences Clone# 4B4-1; Cat# 551137; RRID:AB_394067 IgG Fc secondary Ab Southern Biotech Cat# 2014-09; RRID:AB_2795582 FluoroSpot: Human IFNγ (490) Mabtech, Sweden Cat# FSP-01A-2 Biological samples CHIKV infected and uninfected blood samples Barranquilla, Colombia N/A Chemicals, peptides, and recombinant proteins Synthetic peptides TC Peptide lab https://tcpeptidelab.com/ Critical commercial assays CD4 MicroBeads Miltenyi Biotec Cat# 130-097-048 Deposited data Raw data values This paper Mendeley Data: https://doi.org/10.17632/h6hdnj35x6.1 Software and algorithms FlowJo BD Life Sciences 10.8.1 GraphPad Prism GraphPad Software 10 e1 Cell Reports Medicine 6, 102134, May 20, 2025 ..

    Software:

    Article Title: Chikungunya virus-specific CD4 + T cells are associated with chronic chikungunya viral arthritic disease in humans.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Live/Dead Blue ThermoFisher Cat#L23105 CCR6-BUV496 BD Biosciences Clone# 11A9; Cat# 612948; RRID:AB_2833076 CXCR5-BV421 BioLegend Clone# J252D4; Cat# 356920; RRID:AB_2562303 CXCR3-BV605 BioLegend Clone# G025H7; Cat# 353728; RRID:AB_2563157 CCR7-BV711 BioLegend Clone# G043H7; Cat# 353228; RRID:AB_2563865 CD3-BUV395 BD Biosciences Clone# UCHT1; Cat# 563546; RRID:AB_2744387 CD137-BUV737 BD Biosciences Clone# 4B4-1; Cat# 741861; RRID:AB_2871191 CD8-BUV805 BD Biosciences Clone# SK1; Cat# 612889; RRID:AB_2833078 CD16-BV510 BioLegend Clone# 3G8; Cat# 302048; RRID:AB_2562085 CD14-BV510 BioLegend Clone# 63D3; Cat# 367124; RRID:AB_2716229 CD20-BV510 BioLegend Clone# 2H7; Cat# 302340; RRID:AB_2561941 CD45RA-BV570 BioLegend Clone# HI100; Cat# 304132; RRID:AB_2563813 CD38-BV650 BioLegend Clone# HB-7; Cat# 356620; RRID:AB_2566233 PD-1-BV785 BioLegend Clone# EH12.2H7; Cat# 329930; RRID:AB_2563443 CD69-FITC BioLegend Clone# FN50; Cat# 310904; RRID:AB_314839 CD4-cFluor B548 Cytek Biosciences Clone# SK3; Cat# R7-20043 CD95-BB700 BD Biosciences Clone# DX2; Cat# 566542; RRID:AB_2869780 CD40L-PE-Dazzle594 BioLegend Clone# 24–31; Cat# 310840; RRID:AB_2566245 OX40-APC BioLegend Clone# Ber-Act35; Cat# 350008; RRID:AB_10719958 HLA-DR-APC-R700 BD Biosciences Clone# G46-6; Cat# 565127; RRID:AB_2732055 CD40 Miltenyi Biotec Clone# HB14; Cat# 130-094-133; RRID:AB_10839704 CCR7-PE-Cy7 BioLegend Clone# G043H7; Cat# 353226; RRID:AB_11126145 IL-4-BUV737 BD Biosciences Clone# MP4-25D2; Cat# 612835; RRID:AB_2870157) IL-17-BV785 BioLegend Clone# BL168; Cat# 512338; RRID:AB_2566765 IFNγ-FITC Thermo Fisher Clone# 4S.B3; Cat# 11-7319-82; RRID:AB_465415) IL-2-BB700 BD Biosciences Clone# MQ1-17H12; Cat# 566405; RRID:AB_2744488 IL-10 -PE-Dazzle594 BioLegend Clone# JES3-19F1; Cat# 506812; RRID:AB_2632783 TNFα-eFluor450 Thermo Fisher Clone# Mab11; Cat# 48-7349-42; RRID:AB_2043889 Granzyme B-AF647 BD Biosciences Clone# GB11; Cat# 560212; RRID:AB_11154033 CD40L-PerCP-ef710 Thermo Fisher Clone# 24–31; Cat# 46-1548-42; RRID:AB_10670357 CD137-PE-Cy5 BD Biosciences Clone# 4B4-1; Cat# 551137; RRID:AB_394067 IgG Fc secondary Ab Southern Biotech Cat# 2014-09; RRID:AB_2795582 FluoroSpot: Human IFNγ (490) Mabtech, Sweden Cat# FSP-01A-2 Biological samples CHIKV infected and uninfected blood samples Barranquilla, Colombia N/A Chemicals, peptides, and recombinant proteins Synthetic peptides TC Peptide lab https://tcpeptidelab.com/ Critical commercial assays CD4 MicroBeads Miltenyi Biotec Cat# 130-097-048 Deposited data Raw data values This paper Mendeley Data: https://doi.org/10.17632/h6hdnj35x6.1 Software and algorithms FlowJo BD Life Sciences 10.8.1 GraphPad Prism GraphPad Software 10 e1 Cell Reports Medicine 6, 102134, May 20, 2025 ..

    other:

    Article Title: IMPACT OF THE BIVALENT COVID-19 BOOSTER ON SPIKE-SPECIFIC T CELL RESPONSES
    Article Snippet: cFluor B548 anti-human CD4 , SK3 , Cytek Biosciences , R7-20043 , 1:50.



    Similar Products

    95
    Alomone Labs polyclonal rabbit anti sk3 antibody
    a-c Voltage traces from ventromedial interneurons of the rhythmogenic CPG region (L1-L2) recorded under control conditions ( a ), after tamapin application (10 nM, b ), or after lei-dab7 application (10 nM, c ). d Bar graph showing the proportion of interneurons displaying bursting in response to increasing concentrations of lei-dab7 (teal) or tamapin (purple). e Representative action potentials evoked by near-threshold current injections under control conditions (black), tamapin (purple), or lei-dab7 (teal). f-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying AHP amplitude ( f ), AHP duration ( g ), and firing frequency ( h ) under the three conditions. i-k Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying burst duration ( i ), amplitude ( j ), and frequency ( k ) across interneurons treated with apamin (pink), tamapin (purple), or lei-dab7 (teal). l-o Representative voltage traces from interneurons expressing control shRNA ( l ) or <t>SK3-targeting</t> shRNA ( m-o ), showing heterogeneous bursting phenotypes: bursts at rest/rheobase ( m ), bursts requiring stronger depolarization ( n ), and elliptic bursting dynamics ( o ). p-r Raincloud plots comparing burst duration ( p ), amplitude ( q ), and frequency ( r ) in interneurons after SK3 knockdown (orange) and after apamin application (pink). Numbers in parentheses denote recorded cells; each dot represents a single cell. Data points plotted beyond the dashed vertical line indicate values outside the axis range. n.s., not significant; * P < 0.05; ** P < 0.01; *** P < 0.001 (two-sided Fisher’s exact test for d ; Kruskal-Wallis with Dunn’s post hoc test versus control for f-h and i-k ; two-sided Mann-Whitney test for p-r ). For detailed P values, see Source Data.
    Polyclonal Rabbit Anti Sk3 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/Anti-KCNN3+(KCa2%2E3%2C+SK3)+(N-term)+Antibody/bio_rxiv__64898__2026__03__19__712770-252-30-35
    Average 95 stars, based on 1 article reviews
    polyclonal rabbit anti sk3 antibody - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec clone rea623 | sk3
    a-c Voltage traces from ventromedial interneurons of the rhythmogenic CPG region (L1-L2) recorded under control conditions ( a ), after tamapin application (10 nM, b ), or after lei-dab7 application (10 nM, c ). d Bar graph showing the proportion of interneurons displaying bursting in response to increasing concentrations of lei-dab7 (teal) or tamapin (purple). e Representative action potentials evoked by near-threshold current injections under control conditions (black), tamapin (purple), or lei-dab7 (teal). f-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying AHP amplitude ( f ), AHP duration ( g ), and firing frequency ( h ) under the three conditions. i-k Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying burst duration ( i ), amplitude ( j ), and frequency ( k ) across interneurons treated with apamin (pink), tamapin (purple), or lei-dab7 (teal). l-o Representative voltage traces from interneurons expressing control shRNA ( l ) or <t>SK3-targeting</t> shRNA ( m-o ), showing heterogeneous bursting phenotypes: bursts at rest/rheobase ( m ), bursts requiring stronger depolarization ( n ), and elliptic bursting dynamics ( o ). p-r Raincloud plots comparing burst duration ( p ), amplitude ( q ), and frequency ( r ) in interneurons after SK3 knockdown (orange) and after apamin application (pink). Numbers in parentheses denote recorded cells; each dot represents a single cell. Data points plotted beyond the dashed vertical line indicate values outside the axis range. n.s., not significant; * P < 0.05; ** P < 0.01; *** P < 0.001 (two-sided Fisher’s exact test for d ; Kruskal-Wallis with Dunn’s post hoc test versus control for f-h and i-k ; two-sided Mann-Whitney test for p-r ). For detailed P values, see Source Data.
    Clone Rea623 | Sk3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/CD4+Antibody%2C+anti-human%2C+REAfinity/pm42217184-297-92-96
    Average 96 stars, based on 1 article reviews
    clone rea623 | sk3 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    95
    Alomone Labs rabbit anti sk3
    a-c Voltage traces from ventromedial interneurons of the rhythmogenic CPG region (L1-L2) recorded under control conditions ( a ), after tamapin application (10 nM, b ), or after lei-dab7 application (10 nM, c ). d Bar graph showing the proportion of interneurons displaying bursting in response to increasing concentrations of lei-dab7 (teal) or tamapin (purple). e Representative action potentials evoked by near-threshold current injections under control conditions (black), tamapin (purple), or lei-dab7 (teal). f-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying AHP amplitude ( f ), AHP duration ( g ), and firing frequency ( h ) under the three conditions. i-k Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying burst duration ( i ), amplitude ( j ), and frequency ( k ) across interneurons treated with apamin (pink), tamapin (purple), or lei-dab7 (teal). l-o Representative voltage traces from interneurons expressing control shRNA ( l ) or <t>SK3-targeting</t> shRNA ( m-o ), showing heterogeneous bursting phenotypes: bursts at rest/rheobase ( m ), bursts requiring stronger depolarization ( n ), and elliptic bursting dynamics ( o ). p-r Raincloud plots comparing burst duration ( p ), amplitude ( q ), and frequency ( r ) in interneurons after SK3 knockdown (orange) and after apamin application (pink). Numbers in parentheses denote recorded cells; each dot represents a single cell. Data points plotted beyond the dashed vertical line indicate values outside the axis range. n.s., not significant; * P < 0.05; ** P < 0.01; *** P < 0.001 (two-sided Fisher’s exact test for d ; Kruskal-Wallis with Dunn’s post hoc test versus control for f-h and i-k ; two-sided Mann-Whitney test for p-r ). For detailed P values, see Source Data.
    Rabbit Anti Sk3, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/Anti-KCNN2+Antibody/bio_rxiv__64898__2026__03__19__712770-239-10-14
    Average 95 stars, based on 1 article reviews
    rabbit anti sk3 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Alomone Labs sk3
    Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.
    Sk3, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/Anti-KCNN2+(KCa2%2E2%2C+SK2)+Antibody/pmc13017914-81-18-20
    Average 95 stars, based on 1 article reviews
    sk3 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    94
    Alomone Labs anti kcnn3
    Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.
    Anti Kcnn3, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/Anti-KCNN3+(KCa2%2E3%2C+SK3)+(C-term)+Antibody+-+Carrier+Free/pmc12808508-49-30-35
    Average 94 stars, based on 1 article reviews
    anti kcnn3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Cytek Biosciences sk3
    Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.
    Sk3, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/cFluor+B548+Anti-Human+CD4/pmc12643170-494-5-7
    Average 93 stars, based on 1 article reviews
    sk3 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Alomone Labs anti sk3
    Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.
    Anti Sk3, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/Anti-KCNN3+(KCa2%2E3%2C+SK3)+(C-term)+Antibody/pm41110633-126-42-45
    Average 94 stars, based on 1 article reviews
    anti sk3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    fluidigm cd4 174yb
    Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.
    Cd4 174yb, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sk3/Anti-Human+CD4+(SK3)-174Yb/pmc12484868__41467_2025_63696_MOESM5_ESM-58-71-78
    Average 93 stars, based on 1 article reviews
    cd4 174yb - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    a-c Voltage traces from ventromedial interneurons of the rhythmogenic CPG region (L1-L2) recorded under control conditions ( a ), after tamapin application (10 nM, b ), or after lei-dab7 application (10 nM, c ). d Bar graph showing the proportion of interneurons displaying bursting in response to increasing concentrations of lei-dab7 (teal) or tamapin (purple). e Representative action potentials evoked by near-threshold current injections under control conditions (black), tamapin (purple), or lei-dab7 (teal). f-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying AHP amplitude ( f ), AHP duration ( g ), and firing frequency ( h ) under the three conditions. i-k Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying burst duration ( i ), amplitude ( j ), and frequency ( k ) across interneurons treated with apamin (pink), tamapin (purple), or lei-dab7 (teal). l-o Representative voltage traces from interneurons expressing control shRNA ( l ) or SK3-targeting shRNA ( m-o ), showing heterogeneous bursting phenotypes: bursts at rest/rheobase ( m ), bursts requiring stronger depolarization ( n ), and elliptic bursting dynamics ( o ). p-r Raincloud plots comparing burst duration ( p ), amplitude ( q ), and frequency ( r ) in interneurons after SK3 knockdown (orange) and after apamin application (pink). Numbers in parentheses denote recorded cells; each dot represents a single cell. Data points plotted beyond the dashed vertical line indicate values outside the axis range. n.s., not significant; * P < 0.05; ** P < 0.01; *** P < 0.001 (two-sided Fisher’s exact test for d ; Kruskal-Wallis with Dunn’s post hoc test versus control for f-h and i-k ; two-sided Mann-Whitney test for p-r ). For detailed P values, see Source Data.

    Journal: bioRxiv

    Article Title: SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION

    doi: 10.64898/2026.03.19.712770

    Figure Lengend Snippet: a-c Voltage traces from ventromedial interneurons of the rhythmogenic CPG region (L1-L2) recorded under control conditions ( a ), after tamapin application (10 nM, b ), or after lei-dab7 application (10 nM, c ). d Bar graph showing the proportion of interneurons displaying bursting in response to increasing concentrations of lei-dab7 (teal) or tamapin (purple). e Representative action potentials evoked by near-threshold current injections under control conditions (black), tamapin (purple), or lei-dab7 (teal). f-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying AHP amplitude ( f ), AHP duration ( g ), and firing frequency ( h ) under the three conditions. i-k Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying burst duration ( i ), amplitude ( j ), and frequency ( k ) across interneurons treated with apamin (pink), tamapin (purple), or lei-dab7 (teal). l-o Representative voltage traces from interneurons expressing control shRNA ( l ) or SK3-targeting shRNA ( m-o ), showing heterogeneous bursting phenotypes: bursts at rest/rheobase ( m ), bursts requiring stronger depolarization ( n ), and elliptic bursting dynamics ( o ). p-r Raincloud plots comparing burst duration ( p ), amplitude ( q ), and frequency ( r ) in interneurons after SK3 knockdown (orange) and after apamin application (pink). Numbers in parentheses denote recorded cells; each dot represents a single cell. Data points plotted beyond the dashed vertical line indicate values outside the axis range. n.s., not significant; * P < 0.05; ** P < 0.01; *** P < 0.001 (two-sided Fisher’s exact test for d ; Kruskal-Wallis with Dunn’s post hoc test versus control for f-h and i-k ; two-sided Mann-Whitney test for p-r ). For detailed P values, see Source Data.

    Article Snippet: Equal amounts of protein (40 μg per lane) were separated on 4-15% gradient SDS-PAGE stain-free gels (Bio-Rad), transferred to nitrocellulose membranes, and probed overnight at 4 °C with either a polyclonal rabbit anti-SK3 antibody (1:500, Alomone Labs, APC-025) or an anti-actin antibody (1:1,000, A2066, Sigma-Aldrich) in Tris-buffered saline containing 5% fat-free milk.

    Techniques: Control, Whisker Assay, Expressing, shRNA, Knockdown, Single Cell, MANN-WHITNEY, Patch Clamp

    a Representative low-magnification confocal image of GFP-expressing Hb9 interneurons in the ventromedial spinal cord. The asterisk marks the soma of an identified interneuron. The central canal (cc) is indicated by the dashed line. Scale bar, 25 µm. b High-magnification images of the soma indicated in a , showing GFP fluorescence (top), SK2 immunolabeling (middle), and a merged GFP/SK2 overlay (bottom). Dashed lines delineate the somatic membrane. Scale bar, 10 µm. c-d Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying the size ( c ) and density ( d , clusters per µm 2 ) of SK2, SK3, and co-localized SK2/3 clusters at the somatic membrane. e Confocal images of an Hb9 interneuron soma showing GFP (left), SK3 immunolabeling (middle), and a merged GFP/SK3 overlay (right). Dashed lines delineate the somatic membrane. Scale bar, 20 µm. f Confocal images of an intracellularly recorded HB9 interneuron filled with biocytin (magenta), showing GFP immunofluorescence (green), SK2 (red), and SK3 immunolabeling (cyan), alongside a merged GFP/SK3 signal. Scale bar, 20 µm. g-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying the size ( g ) and density ( h ) of SK2, SK3, and co-localized clusters along the dendrites. Numbers in parentheses denote the number of cells ( c, d ) or dendrites ( g, h ) analyzed; each dot represents a single measurement. *** P < 0.001 (two-sided unpaired t-test for c and g ; One-way ANOVA for d and h ). For detailed P values, see Source data.

    Journal: bioRxiv

    Article Title: SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION

    doi: 10.64898/2026.03.19.712770

    Figure Lengend Snippet: a Representative low-magnification confocal image of GFP-expressing Hb9 interneurons in the ventromedial spinal cord. The asterisk marks the soma of an identified interneuron. The central canal (cc) is indicated by the dashed line. Scale bar, 25 µm. b High-magnification images of the soma indicated in a , showing GFP fluorescence (top), SK2 immunolabeling (middle), and a merged GFP/SK2 overlay (bottom). Dashed lines delineate the somatic membrane. Scale bar, 10 µm. c-d Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying the size ( c ) and density ( d , clusters per µm 2 ) of SK2, SK3, and co-localized SK2/3 clusters at the somatic membrane. e Confocal images of an Hb9 interneuron soma showing GFP (left), SK3 immunolabeling (middle), and a merged GFP/SK3 overlay (right). Dashed lines delineate the somatic membrane. Scale bar, 20 µm. f Confocal images of an intracellularly recorded HB9 interneuron filled with biocytin (magenta), showing GFP immunofluorescence (green), SK2 (red), and SK3 immunolabeling (cyan), alongside a merged GFP/SK3 signal. Scale bar, 20 µm. g-h Raincloud plots with box-and-whisker overlays (median, interquartile range) quantifying the size ( g ) and density ( h ) of SK2, SK3, and co-localized clusters along the dendrites. Numbers in parentheses denote the number of cells ( c, d ) or dendrites ( g, h ) analyzed; each dot represents a single measurement. *** P < 0.001 (two-sided unpaired t-test for c and g ; One-way ANOVA for d and h ). For detailed P values, see Source data.

    Article Snippet: Equal amounts of protein (40 μg per lane) were separated on 4-15% gradient SDS-PAGE stain-free gels (Bio-Rad), transferred to nitrocellulose membranes, and probed overnight at 4 °C with either a polyclonal rabbit anti-SK3 antibody (1:500, Alomone Labs, APC-025) or an anti-actin antibody (1:1,000, A2066, Sigma-Aldrich) in Tris-buffered saline containing 5% fat-free milk.

    Techniques: Confocal, Expressing, Fluorescence, Immunolabeling, Membrane, Whisker Assay, Immunofluorescence

    Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.

    Journal: Frontiers in Pharmacology

    Article Title: Compensatory attenuation of cortical apoptosis by SK2 downregulation following ketamine anesthesia

    doi: 10.3389/fphar.2026.1761187

    Figure Lengend Snippet: Apamin-sensitive SK2 channel-mediated mAHP currents may be linked to changes in neuronal spike frequency and adaptation at 24 h post-ketamine anesthesia. (A,B) Representative traces (A) and amplitudes (B) of the mAHP currents, treatment conditions as indicated. S1 slices from control (Ctrl) and ketamine-treated (Ket) rats were separately incubated and perfused with apamin (100 nM) or its vehicle. 22–25 neurons from 7–10 rats were used per condition. (C) Plots of spike frequency vs. current injected for layer II/III pyramidal neurons of S1. The significant differences in the spike frequency between the Ctrl and Ket groups (Ctrl: Vehicle vs. Ket: Vehicle, 80 pA, 100 pA and 110 pA, P < 0.01; 90 pA, P < 0.001) were eliminated after apamin treatment (Ctrl: Apamin vs. Ket: Apamin, P > 0.05). 20–22 neurons from 7–9 rats were recorded per condition. (D,E) Spikes in S1 layer II/III pyramidal neurons evoked for 3 s, 80 pA current injection (D) , and the adaptation index (E) was obtained by the algorithm mentioned above. 18–20 neurons from 7–9 rats were recorded per condition. (F) Quantitative analysis of SK1-3 mRNA in S1 of P8 rats. 5 rats were used per condition. P > 0.05. (G,H) Immunoblots and quantitative analysis of total (G) and membrane-bound (H) SK1-3 levels in S1 of ketamine-treated rats, normalized to corresponding levels in control rats. 8–12 rats were used per condition. * P < 0.05, ** P < 0.01, *** P < 0.001; n.s ., not significant. Data were analyzed using the Mann-Whitney U test for (F,H) and unpaired two-tailed Student’s t-tests for the other panels. Data are shown as the mean ± SEM.

    Article Snippet: The following primary antibodies were used: SK1 (1:500, Alomone Labs, Cat# APC-039), SK2 (1:500, Alomone Labs, Cat# APC-028), SK3 (1:500, Alomone Labs, Cat# APC-025), β-actin (1:1,000, Millipore, Cat# A1978 ), and pan-cadherin (1:1,000, Sigma-Aldrich, Cat# SAB4500001 ).

    Techniques: Anesthesia, Control, Incubation, Injection, Analysis, Western Blot, Membrane, MANN-WHITNEY, Two Tailed Test, Patch Clamp, Real-time Polymerase Chain Reaction